United States · FDA National Drug Code directory
BIVALIRUDIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71288-427_2b20b742-4bab-4e5b-9d1b-9a7ca9e0daf7
- Product NDC
- 71288-427
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- BIVALIRUDIN
- Labeler
- Meitheal Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180716
- Source listing expiry
- 20261231
Source-listed ingredients
- BIVALIRUDIN — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-427-11) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-427-10) · 71288-427-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →